Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey R Oxnard

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Archives of Pathology & Laboratory Medicine|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung CancerBruna Pellini, Russell W Madison, Merrida A Childress, et al.
JCO Precision Oncology|October 5, 2020
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement AnalysisYi Lee, Evan W Clark, Marina S D Milan, et al.
Cancer Discovery|December 3, 2020
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American PopulationsJian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
NPJ Precision Oncology|December 9, 2022
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumorsJessica K Lee, Smruthy Sivakumar, Alexa B Schrock, et al.
Nature Medicine|March 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancerZoe June F Assaf, Wei Zou, Alexander D Fine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.
The Journal of Liquid Biopsy|March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREENSaori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Archives of Pathology & Laboratory Medicine|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung CancerBruna Pellini, Russell W Madison, Merrida A Childress, et al.
JCO Precision Oncology|October 5, 2020
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement AnalysisYi Lee, Evan W Clark, Marina S D Milan, et al.
Cancer Discovery|December 3, 2020
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American PopulationsJian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
NPJ Precision Oncology|December 9, 2022
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumorsJessica K Lee, Smruthy Sivakumar, Alexa B Schrock, et al.
Nature Medicine|March 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancerZoe June F Assaf, Wei Zou, Alexander D Fine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.
The Journal of Liquid Biopsy|March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREENSaori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Pageof 20